Celltrion wins approval for allergic asthma treatment biosimilar in Canada - Yes Punjab News South Korea's Celltrion has received approval from Health Canada for its biosimilar treatment, Omlyclo, for allergic asthma. The company plans to expand its presence in Canada, with a third manufactur...

Celltrion wins approval for allergic asthma treatment biosimilar in Canada
yespunjab.com?p=71183

#Celltrion #BiosimilarTreatment #Asthma #Omlyclo #Xolair #HealthCanada #PharmaceuticalIndustry #Biosimilar #DrugManufacturing #Canada